162 related articles for article (PubMed ID: 37046682)
1. BI-D1870 Induces Mitotic Dysfunction and Apoptosis in Neuroblastoma by Regulating the PI3K-Akt-mTORC1 Signal Axis.
Jin L; Mi T; Wu X; Wang Z; Zhang Z; Liu J; Wang Z; Wang J; Li M; Ren C; Guo P; He D
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046682
[No Abstract] [Full Text] [Related]
2. Two widely used RSK inhibitors, BI-D1870 and SL0101, alter mTORC1 signaling in a RSK-independent manner.
Roffé M; Lupinacci FC; Soares LC; Hajj GN; Martins VR
Cell Signal; 2015 Aug; 27(8):1630-42. PubMed ID: 25889895
[TBL] [Abstract][Full Text] [Related]
3. RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit.
Chae HD; Dutta R; Tiu B; Hoff FW; Accordi B; Serafin V; Youn M; Huang M; Sumarsono N; Davis KL; Lacayo NJ; Pigazzi M; Horton TM; Kornblau SM; Sakamoto KM
Oncotarget; 2020 Jun; 11(25):2387-2403. PubMed ID: 32637030
[TBL] [Abstract][Full Text] [Related]
4. RSK Inhibition Induces Apoptosis by Downregulating Protein Synthesis in a Variety of Acute Myeloid Leukemia Cell Lines.
Katayama K; Nishihata A
Biol Pharm Bull; 2021 Dec; 44(12):1843-1850. PubMed ID: 34602526
[TBL] [Abstract][Full Text] [Related]
5. The p90 ribosomal S6 kinase (RSK) inhibitor BI-D1870 prevents gamma irradiation-induced apoptosis and mediates senescence via RSK- and p53-independent accumulation of p21WAF1/CIP1.
Neise D; Sohn D; Stefanski A; Goto H; Inagaki M; Wesselborg S; Budach W; Stühler K; Jänicke RU
Cell Death Dis; 2013 Oct; 4(10):e859. PubMed ID: 24136223
[TBL] [Abstract][Full Text] [Related]
6. Overcoming resistance to Sonic Hedgehog inhibition by targeting p90 ribosomal S6 kinase in pediatric medulloblastoma.
Pambid MR; Berns R; Adomat HH; Hu K; Triscott J; Maurer N; Zisman N; Ramaswamy V; Hawkins CE; Taylor MD; Dunham C; Guns E; Dunn SE
Pediatr Blood Cancer; 2014 Jan; 61(1):107-15. PubMed ID: 23940083
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effects of BI-D1870 on human oral squamous cell carcinoma.
Chiu CF; Bai LY; Kapuriya N; Peng SY; Wu CY; Sargeant AM; Chen MY; Weng JR
Cancer Chemother Pharmacol; 2014 Feb; 73(2):237-47. PubMed ID: 24241211
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of p90 ribosomal S6 kinase potentiates cisplatin activity in A549 human lung adenocarcinoma cells.
Abdulrahman N; Siveen KS; Joseph JM; Osman A; Yalcin HC; Hasan A; Uddin S; Mraiche F
J Pharm Pharmacol; 2020 Nov; 72(11):1536-1545. PubMed ID: 32667058
[TBL] [Abstract][Full Text] [Related]
9. A combination of SILAC and nucleotide acyl phosphate labelling reveals unexpected targets of the Rsk inhibitor BI-D1870.
Edgar AJ; Trost M; Watts C; Zaru R
Biosci Rep; 2014 Feb; 34(1):. PubMed ID: 27919044
[TBL] [Abstract][Full Text] [Related]
10. BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo.
Sapkota GP; Cummings L; Newell FS; Armstrong C; Bain J; Frodin M; Grauert M; Hoffmann M; Schnapp G; Steegmaier M; Cohen P; Alessi DR
Biochem J; 2007 Jan; 401(1):29-38. PubMed ID: 17040210
[TBL] [Abstract][Full Text] [Related]
11. Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma.
Kling MJ; Griggs CN; McIntyre EM; Alexander G; Ray S; Challagundla KB; Joshi SS; Coulter DW; Chaturvedi NK
BMC Cancer; 2021 Sep; 21(1):1061. PubMed ID: 34565342
[TBL] [Abstract][Full Text] [Related]
12. DRAM1 regulates autophagy and cell proliferation via inhibition of the phosphoinositide 3-kinase-Akt-mTOR-ribosomal protein S6 pathway.
Lu T; Zhu Z; Wu J; She H; Han R; Xu H; Qin ZH
Cell Commun Signal; 2019 Mar; 17(1):28. PubMed ID: 30902093
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor effect of AZD8055 against neuroblastoma cells in vitro and in vivo.
Xu DQ; Toyoda H; Yuan XJ; Qi L; Chelakkot VS; Morimoto M; Hanaki R; Kihira K; Hori H; Komada Y; Hirayama M
Exp Cell Res; 2018 Apr; 365(2):177-184. PubMed ID: 29499203
[TBL] [Abstract][Full Text] [Related]
14. The dual role of BI 2536, a small-molecule inhibitor that targets PLK1, in induction of apoptosis and attenuation of autophagy in neuroblastoma cells.
Li Z; Yang C; Li X; Du X; Tao Y; Ren J; Fang F; Xie Y; Li M; Qian G; Xu L; Cao X; Wu Y; Lv H; Hu S; Lu J; Pan J
J Cancer; 2020; 11(11):3274-3287. PubMed ID: 32231733
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of NHE1 phosphorylation and glucose uptake by inhibitors of the ERK pathway and p90RSK in 3T3-L1 adipocytes.
Chen S; Mackintosh C
Cell Signal; 2009 Dec; 21(12):1984-93. PubMed ID: 19765648
[TBL] [Abstract][Full Text] [Related]
16. Apatinib induces apoptosis and autophagy via the PI3K/AKT/mTOR and MAPK/ERK signaling pathways in neuroblastoma.
Yu X; Fan H; Jiang X; Zheng W; Yang Y; Jin M; Ma X; Jiang W
Oncol Lett; 2020 Oct; 20(4):52. PubMed ID: 32788939
[TBL] [Abstract][Full Text] [Related]
17. Polo-like kinase 1 inhibition sensitizes neuroblastoma cells for vinca alkaloid-induced apoptosis.
Czaplinski S; Hugle M; Stiehl V; Fulda S
Oncotarget; 2016 Feb; 7(8):8700-11. PubMed ID: 26046302
[TBL] [Abstract][Full Text] [Related]
18. Divergent off-target effects of RSK N-terminal and C-terminal kinase inhibitors in cardiac myocytes.
Stathopoulou K; Schobesberger S; Bork NI; Sprenger JU; Perera RK; Sotoud H; Geertz B; David JP; Christ T; Nikolaev VO; Cuello F
Cell Signal; 2019 Nov; 63():109362. PubMed ID: 31344438
[TBL] [Abstract][Full Text] [Related]
19. The ribosomal S6 kinase inhibitor BI-D1870 ameliorated experimental autoimmune encephalomyelitis in mice.
Takada I; Yogiashi Y; Makishima M
Immunobiology; 2016 Feb; 221(2):188-92. PubMed ID: 26386981
[TBL] [Abstract][Full Text] [Related]
20.
Jin Q; Chen Y; Du S; Xu D; Yue J; Cai L; Yuan X
Curr Cancer Drug Targets; 2022; 22(11):919-930. PubMed ID: 35909289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
